Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malawi | 31 | 2024 | 282 | 2.310 |
Why?
|
Hospitals, Rural | 1 | 2023 | 172 | 0.790 |
Why?
|
Personnel Selection | 2 | 2019 | 189 | 0.750 |
Why?
|
HIV Infections | 13 | 2022 | 16718 | 0.730 |
Why?
|
Rural Health Services | 2 | 2018 | 379 | 0.590 |
Why?
|
Health Services Administration | 1 | 2017 | 64 | 0.580 |
Why?
|
Malnutrition | 2 | 2021 | 625 | 0.530 |
Why?
|
Rural Population | 11 | 2022 | 2210 | 0.480 |
Why?
|
Health Services Research | 2 | 2019 | 1836 | 0.450 |
Why?
|
Hypertension | 7 | 2024 | 8480 | 0.440 |
Why?
|
Communicable Diseases | 2 | 2018 | 880 | 0.430 |
Why?
|
Public Health | 2 | 2021 | 2603 | 0.380 |
Why?
|
Interviews as Topic | 1 | 2017 | 2539 | 0.370 |
Why?
|
Tuberculosis | 2 | 2021 | 1912 | 0.340 |
Why?
|
Clinical Competence | 3 | 2019 | 4687 | 0.300 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.280 |
Why?
|
Biopsy | 1 | 2018 | 6756 | 0.280 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2014 | 1873 | 0.260 |
Why?
|
Patient Compliance | 2 | 2021 | 2684 | 0.250 |
Why?
|
Health Policy | 4 | 2019 | 2661 | 0.250 |
Why?
|
Asthma | 1 | 2022 | 6011 | 0.230 |
Why?
|
Sarcoma, Kaposi | 2 | 2018 | 370 | 0.230 |
Why?
|
Primary Health Care | 2 | 2018 | 4558 | 0.220 |
Why?
|
Program Evaluation | 4 | 2021 | 2488 | 0.210 |
Why?
|
Africa South of the Sahara | 3 | 2023 | 724 | 0.210 |
Why?
|
Drugs, Essential | 1 | 2022 | 73 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 3 | 2020 | 3022 | 0.190 |
Why?
|
Patents as Topic | 1 | 2021 | 103 | 0.190 |
Why?
|
Liberia | 1 | 2021 | 167 | 0.190 |
Why?
|
Policy Making | 3 | 2019 | 554 | 0.180 |
Why?
|
World Health Organization | 2 | 2023 | 1318 | 0.170 |
Why?
|
Depression | 2 | 2021 | 7766 | 0.170 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5391 | 0.170 |
Why?
|
Capacity Building | 2 | 2019 | 248 | 0.170 |
Why?
|
Health Facilities | 2 | 2024 | 573 | 0.170 |
Why?
|
Humans | 45 | 2024 | 744343 | 0.170 |
Why?
|
Moral Obligations | 1 | 2019 | 96 | 0.160 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2017 | 941 | 0.160 |
Why?
|
Perinatal Care | 1 | 2020 | 227 | 0.150 |
Why?
|
Internship and Residency | 1 | 2017 | 5788 | 0.150 |
Why?
|
Health Literacy | 1 | 2021 | 414 | 0.140 |
Why?
|
Community Health Services | 1 | 2021 | 650 | 0.140 |
Why?
|
Proteinuria | 1 | 2019 | 658 | 0.140 |
Why?
|
Social Identification | 1 | 2016 | 103 | 0.140 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2022 | 3336 | 0.140 |
Why?
|
Family Characteristics | 1 | 2021 | 1000 | 0.140 |
Why?
|
Inservice Training | 1 | 2018 | 392 | 0.130 |
Why?
|
Minority Health | 1 | 2016 | 87 | 0.130 |
Why?
|
Stavudine | 1 | 2015 | 85 | 0.130 |
Why?
|
Fees and Charges | 1 | 2016 | 195 | 0.130 |
Why?
|
Mass Screening | 3 | 2020 | 5255 | 0.130 |
Why?
|
Pregnant Women | 1 | 2020 | 568 | 0.130 |
Why?
|
Research Personnel | 1 | 2019 | 573 | 0.120 |
Why?
|
Evidence-Based Medicine | 2 | 2017 | 3610 | 0.120 |
Why?
|
Critical Care | 3 | 2023 | 2647 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1320 | 0.120 |
Why?
|
Nevirapine | 1 | 2015 | 267 | 0.120 |
Why?
|
Lamivudine | 1 | 2015 | 342 | 0.120 |
Why?
|
Chronic Disease | 3 | 2023 | 9146 | 0.120 |
Why?
|
Human Rights | 1 | 2016 | 307 | 0.120 |
Why?
|
Critical Illness | 2 | 2023 | 2670 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 11725 | 0.110 |
Why?
|
Intensive Care Units | 2 | 2023 | 3679 | 0.110 |
Why?
|
Poverty | 3 | 2023 | 2660 | 0.110 |
Why?
|
Needs Assessment | 1 | 2019 | 1147 | 0.110 |
Why?
|
Adult | 15 | 2023 | 214055 | 0.110 |
Why?
|
Health Plan Implementation | 1 | 2015 | 352 | 0.110 |
Why?
|
Pregnancy | 5 | 2021 | 29144 | 0.110 |
Why?
|
Retrospective Studies | 5 | 2023 | 77449 | 0.100 |
Why?
|
Home Care Services | 1 | 2018 | 606 | 0.100 |
Why?
|
Employment | 1 | 2018 | 1132 | 0.100 |
Why?
|
Rwanda | 1 | 2014 | 703 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2518 | 0.100 |
Why?
|
Cost of Illness | 1 | 2020 | 1859 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2214 | 0.090 |
Why?
|
Educational Measurement | 1 | 2017 | 1210 | 0.090 |
Why?
|
Neoplasms | 2 | 2018 | 21683 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2026 | 0.090 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5751 | 0.090 |
Why?
|
Female | 16 | 2021 | 380194 | 0.090 |
Why?
|
Minority Groups | 1 | 2016 | 1223 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 9959 | 0.080 |
Why?
|
Africa | 2 | 2023 | 673 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2020 | 0.080 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5137 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4253 | 0.070 |
Why?
|
Prevalence | 4 | 2019 | 15226 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1411 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2018 | 3923 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25043 | 0.060 |
Why?
|
Ambulatory Care Facilities | 2 | 2024 | 933 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2208 | 0.060 |
Why?
|
Male | 11 | 2020 | 350118 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1439 | 0.060 |
Why?
|
Hospitals | 3 | 2023 | 3952 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2400 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
Beclomethasone | 1 | 2024 | 38 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3605 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4644 | 0.060 |
Why?
|
Young Adult | 4 | 2018 | 56430 | 0.060 |
Why?
|
Hospitals, District | 1 | 2024 | 106 | 0.060 |
Why?
|
Self Report | 1 | 2014 | 3558 | 0.060 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.050 |
Why?
|
Censuses | 1 | 2024 | 200 | 0.050 |
Why?
|
Viral Load | 2 | 2021 | 3299 | 0.050 |
Why?
|
Middle Aged | 9 | 2020 | 213383 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5319 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Senegal | 1 | 2020 | 294 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.040 |
Why?
|
Nepal | 1 | 2020 | 295 | 0.040 |
Why?
|
Palliative Care | 1 | 2014 | 3493 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2020 | 207 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19905 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5686 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2022 | 434 | 0.040 |
Why?
|
Bangladesh | 1 | 2020 | 687 | 0.040 |
Why?
|
Ethiopia | 1 | 2020 | 495 | 0.040 |
Why?
|
Haiti | 1 | 2020 | 553 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4256 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 53288 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 194 | 0.040 |
Why?
|
Developing Countries | 2 | 2021 | 2815 | 0.040 |
Why?
|
Social Control Policies | 1 | 2017 | 9 | 0.040 |
Why?
|
Ethics, Research | 1 | 2019 | 191 | 0.040 |
Why?
|
Live Birth | 1 | 2021 | 512 | 0.040 |
Why?
|
India | 1 | 2024 | 2197 | 0.040 |
Why?
|
Politics | 1 | 2024 | 791 | 0.040 |
Why?
|
Myanmar | 1 | 2016 | 45 | 0.040 |
Why?
|
Mentors | 1 | 2021 | 631 | 0.030 |
Why?
|
Blood Glucose | 2 | 2022 | 6256 | 0.030 |
Why?
|
Kenya | 1 | 2018 | 685 | 0.030 |
Why?
|
Tanzania | 1 | 2020 | 1346 | 0.030 |
Why?
|
Family Planning Services | 1 | 2018 | 263 | 0.030 |
Why?
|
Risk Factors | 5 | 2021 | 72290 | 0.030 |
Why?
|
Maternal Health Services | 1 | 2020 | 455 | 0.030 |
Why?
|
Aged | 4 | 2019 | 163280 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1919 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1769 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57776 | 0.030 |
Why?
|
Child | 1 | 2021 | 77709 | 0.030 |
Why?
|
Breast Feeding | 1 | 2021 | 1338 | 0.030 |
Why?
|
Comorbidity | 2 | 2019 | 10388 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2024 | 2708 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1863 | 0.030 |
Why?
|
Health Priorities | 1 | 2015 | 380 | 0.030 |
Why?
|
Geography | 1 | 2014 | 669 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2022 | 5078 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2170 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2715 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20822 | 0.020 |
Why?
|
Prenatal Care | 1 | 2018 | 1092 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 40561 | 0.020 |
Why?
|
Health Resources | 1 | 2017 | 911 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 25625 | 0.020 |
Why?
|
Health Expenditures | 1 | 2021 | 2348 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3528 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2015 | 1071 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2616 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.020 |
Why?
|
Qualitative Research | 1 | 2014 | 2682 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5102 | 0.020 |
Why?
|
Pain Measurement | 1 | 2014 | 3420 | 0.020 |
Why?
|
Blood Pressure | 1 | 2019 | 8554 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 5987 | 0.010 |
Why?
|
Caregivers | 1 | 2014 | 2094 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12804 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13989 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_